Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.98 USD | +4.86% | +6.36% | -28.31% |
01:15am | Transcript : Immunocore Holdings plc - Special Call | |
29/05 | Immunocore Converts Skin Cancer Therapy Phase 2/3 Trial to Phase 3 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.31% | 244.96Cr | |
+40.73% | 74TCr | |
+32.83% | 60TCr | |
-6.30% | 35TCr | |
+15.15% | 32TCr | |
+4.05% | 28TCr | |
+15.00% | 24TCr | |
-5.52% | 21TCr | |
+6.17% | 16TCr | |
-0.45% | 16TCr |
- Stock Market
- Equities
- IMCR Stock
- News Immunocore Holdings plc
- Morgan Stanley Adjusts Price Target on Immunocore Holdings to $79 From $72, Maintains Overweight Rating